Hyperuricemia as a biomarker of severe #PsA? Study of 242 PsA pts 30% had hyperuricemia & 6% had gout. Hyperuricemia was significantly associated with age, comorbidity, perph polyarthritis, Jt destruction, less response to treatment. https://t.co/NiPTbknD57 https://t.co/HOC2Bev4R6

• https://bit.ly/3vXqPd9

We completed a whole month of super-charged, focused coverage & education on #PsA.THANKS to the many mavens who contributed! In PSA - "Unless someone like you cares a whole awful lot, nothing is going to get better. It’s not." -Dr. Seuss, The Lorax https://t.co/Y58klwbS4V https://t.co/f2pnuypwyr

• https://bit.ly/38LGYus

Study of 33 #RA pts finds nearly half had peripheral neuropathy (48.5%); sensorimotor in 64.7%, motor in 17.6%. Neuropathy was NOT associated with age, gender, disease activity, functionality, or falls https://t.co/r2aQI2cm27 https://t.co/OOQlWkCAft

• https://bit.ly/3vB0OBG

Prolonged TNF Inhibitor Use Delays Sacroiliac Progression https://t.co/dz4d8q8XSy https://t.co/NWCAb0OH7B

• https://bit.ly/3wdr0kX

Intraarticular Steroids in Hip Osteoarthritis - Do They Work? https://t.co/AP9jo96xQo https://t.co/tYvP20Qpqh

• https://bit.ly/3OK2cJF

Playback now available! Watch our Tuesday Nite Rheumatology, held April 26th, 2022, which featured a Journal Club panel discussion about two important studies. https://t.co/RjFRFt6oJQ https://t.co/zOxCDC1atS

• https://bit.ly/3F4hyUF

Biologics for JIA? Not So Fast, Say Insurers It's not a simple matter to prescribe tumor necrosis factor (TNF) inhibitors for patients with juvenile idiopathic arthritis (JIA), at least those with insurance, a single-center study found. https://t.co/w4A5sgv3fU https://t.co/coVh3zui2z

• https://bit.ly/3MCXagb

Arthritis Predicts Hepatic Fibrosis in Hemochromatosis https://t.co/AHnRkvq2wo https://t.co/zbl3HQRZCX

• https://bit.ly/3KAbdBv

Today the FDA expanded the indications for upadacitinib (Rinvoq) to include ankylosing spondylitis - specifically for adults w/ active ankylosing spondylitis after failing a TNF blockers or other DMARDs. https://t.co/A9QhT98Djj

• https://bit.ly/3kouOdB

Study of PCP Dx irritable bowel dz; 459 randomised to 8 weeks of oral antispasmodics or diet (low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP). Better responses with diet (71% vs 61%; p=0.03). Better adherence w/ diet. https://t.co/gmn45yQmuB https://t.co/8SP5Vfx71z

• https://bit.ly/37S9E4O